[BAT] QoQ Quarter Result on 30-Sep-2017 [#3]

Stock
[BAT] BRITISH AMERICAN TOBACCO (M)
Announcement Date
23-Oct-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- -0.62%
YoY- -32.66%
Quarter Report
Latest QR
Upcoming QR
BAT's Result
BAT's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 679,146 637,649 700,163 757,282 774,090 748,374 840,613 -13.28%
PBT 148,797 126,626 101,995 186,871 193,976 156,384 316,491 -39.62%
Tax -38,664 -30,400 -20,956 -41,377 -46,666 -37,591 -27,159 26.63%
NP 110,133 96,226 81,039 145,494 147,310 118,793 289,332 -47.57%
-
NP to SH 113,724 95,884 78,198 143,179 144,078 114,233 299,116 -47.61%
-
Tax Rate 25.98% 24.01% 20.55% 22.14% 24.06% 24.04% 8.58% -
Total Cost 569,013 541,423 619,124 611,788 626,780 629,581 551,281 2.13%
-
Net Worth 374,044 354,057 382,610 425,439 405,452 376,899 613,889 -28.19%
Dividend
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Div 99,935 94,224 122,777 122,777 122,777 114,212 219,858 -40.96%
Div Payout % 87.88% 98.27% 157.01% 85.75% 85.22% 99.98% 73.50% -
Equity
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Net Worth 374,044 354,057 382,610 425,439 405,452 376,899 613,889 -28.19%
NOSH 285,530 285,530 285,530 285,530 285,530 285,530 285,530 0.00%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 16.22% 15.09% 11.57% 19.21% 19.03% 15.87% 34.42% -
ROE 30.40% 27.08% 20.44% 33.65% 35.54% 30.31% 48.72% -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 237.85 223.32 245.22 265.22 271.11 262.10 294.40 -13.28%
EPS 38.60 33.70 28.40 51.00 51.60 41.60 101.30 -47.53%
DPS 35.00 33.00 43.00 43.00 43.00 40.00 77.00 -40.96%
NAPS 1.31 1.24 1.34 1.49 1.42 1.32 2.15 -28.19%
Adjusted Per Share Value based on latest NOSH - 285,530
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 237.85 223.32 245.22 265.22 271.11 262.10 294.40 -13.28%
EPS 38.60 33.70 28.40 51.00 51.60 41.60 101.30 -47.53%
DPS 35.00 33.00 43.00 43.00 43.00 40.00 77.00 -40.96%
NAPS 1.31 1.24 1.34 1.49 1.42 1.32 2.15 -28.19%
Price Multiplier on Financial Quarter End Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 -
Price 34.78 26.42 40.00 43.74 43.42 45.60 44.60 -
P/RPS 14.62 11.83 16.31 16.49 16.02 17.40 15.15 -2.35%
P/EPS 87.32 78.68 146.05 87.23 86.05 113.98 42.57 61.65%
EY 1.15 1.27 0.68 1.15 1.16 0.88 2.35 -37.98%
DY 1.01 1.25 1.08 0.98 0.99 0.88 1.73 -30.21%
P/NAPS 26.55 21.31 29.85 29.36 30.58 34.55 20.74 17.95%
Price Multiplier on Announcement Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 20/07/18 21/05/18 13/02/18 23/10/17 20/07/17 20/04/17 16/02/17 -
Price 33.68 33.40 32.88 42.60 43.88 47.06 48.78 -
P/RPS 14.16 14.96 13.41 16.06 16.19 17.95 16.57 -9.97%
P/EPS 84.56 99.46 120.06 84.95 86.96 117.63 46.56 49.01%
EY 1.18 1.01 0.83 1.18 1.15 0.85 2.15 -33.03%
DY 1.04 0.99 1.31 1.01 0.98 0.85 1.58 -24.38%
P/NAPS 25.71 26.94 24.54 28.59 30.90 35.65 22.69 8.71%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment